Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL

Ting Yu Chang, Hsin An Chen, Ching Feng Chiu, Yi Wen Chang, Tsang Chih Kuo, Po Chun Tseng, Weu Wang, Mien Chie Hung, Jen Liang Su

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Paclitaxel is a standard-of-care chemotherapy for breast cancer, despite the increasing recognition of its poor effectiveness in the treatment of patients with advanced disease. Here, we report that adenovirus-type 5 E1A-mediated elevation of the miRNA-processing enzyme Dicer is sufficient to enhance paclitaxel sensitization and reduce cancer stem-like cell properties in this setting. Elevating Dicer expression increased levels of the AXL kinase targeting miRNA miR-494, thereby repressing AXL expression to increase paclitaxel sensitivity. We found that Dicer expression was regulated at the transcription level by E1A, through activation of an MAPK14/CEBPα pathway. Our findings define a mechanism of E1A-mediated chemosensitization for paclitaxel, which is based upon the suppression of breast cancer stem-like cells, with potential implications for the diagnosis and treatment of breast cancer patients.

Original languageEnglish
Pages (from-to)3916-3928
Number of pages13
JournalCancer Research
Volume76
Issue number13
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Paclitaxel
Breast Neoplasms
Neoplastic Stem Cells
MicroRNAs
Neoplasms
Mitogen-Activated Protein Kinase 14
Ribonuclease III
Standard of Care
Adenoviridae
Phosphotransferases
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL. / Chang, Ting Yu; Chen, Hsin An; Chiu, Ching Feng; Chang, Yi Wen; Kuo, Tsang Chih; Tseng, Po Chun; Wang, Weu; Hung, Mien Chie; Su, Jen Liang.

In: Cancer Research, Vol. 76, No. 13, 01.07.2016, p. 3916-3928.

Research output: Contribution to journalArticle

Chang, Ting Yu ; Chen, Hsin An ; Chiu, Ching Feng ; Chang, Yi Wen ; Kuo, Tsang Chih ; Tseng, Po Chun ; Wang, Weu ; Hung, Mien Chie ; Su, Jen Liang. / Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL. In: Cancer Research. 2016 ; Vol. 76, No. 13. pp. 3916-3928.
@article{388e53986e004094b89c3433e2c79a98,
title = "Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL",
abstract = "Paclitaxel is a standard-of-care chemotherapy for breast cancer, despite the increasing recognition of its poor effectiveness in the treatment of patients with advanced disease. Here, we report that adenovirus-type 5 E1A-mediated elevation of the miRNA-processing enzyme Dicer is sufficient to enhance paclitaxel sensitization and reduce cancer stem-like cell properties in this setting. Elevating Dicer expression increased levels of the AXL kinase targeting miRNA miR-494, thereby repressing AXL expression to increase paclitaxel sensitivity. We found that Dicer expression was regulated at the transcription level by E1A, through activation of an MAPK14/CEBPα pathway. Our findings define a mechanism of E1A-mediated chemosensitization for paclitaxel, which is based upon the suppression of breast cancer stem-like cells, with potential implications for the diagnosis and treatment of breast cancer patients.",
author = "Chang, {Ting Yu} and Chen, {Hsin An} and Chiu, {Ching Feng} and Chang, {Yi Wen} and Kuo, {Tsang Chih} and Tseng, {Po Chun} and Weu Wang and Hung, {Mien Chie} and Su, {Jen Liang}",
year = "2016",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-15-2555",
language = "English",
volume = "76",
pages = "3916--3928",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Dicer elicits paclitaxel chemosensitization and suppresses cancer stemness in breast cancer by repressing AXL

AU - Chang, Ting Yu

AU - Chen, Hsin An

AU - Chiu, Ching Feng

AU - Chang, Yi Wen

AU - Kuo, Tsang Chih

AU - Tseng, Po Chun

AU - Wang, Weu

AU - Hung, Mien Chie

AU - Su, Jen Liang

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Paclitaxel is a standard-of-care chemotherapy for breast cancer, despite the increasing recognition of its poor effectiveness in the treatment of patients with advanced disease. Here, we report that adenovirus-type 5 E1A-mediated elevation of the miRNA-processing enzyme Dicer is sufficient to enhance paclitaxel sensitization and reduce cancer stem-like cell properties in this setting. Elevating Dicer expression increased levels of the AXL kinase targeting miRNA miR-494, thereby repressing AXL expression to increase paclitaxel sensitivity. We found that Dicer expression was regulated at the transcription level by E1A, through activation of an MAPK14/CEBPα pathway. Our findings define a mechanism of E1A-mediated chemosensitization for paclitaxel, which is based upon the suppression of breast cancer stem-like cells, with potential implications for the diagnosis and treatment of breast cancer patients.

AB - Paclitaxel is a standard-of-care chemotherapy for breast cancer, despite the increasing recognition of its poor effectiveness in the treatment of patients with advanced disease. Here, we report that adenovirus-type 5 E1A-mediated elevation of the miRNA-processing enzyme Dicer is sufficient to enhance paclitaxel sensitization and reduce cancer stem-like cell properties in this setting. Elevating Dicer expression increased levels of the AXL kinase targeting miRNA miR-494, thereby repressing AXL expression to increase paclitaxel sensitivity. We found that Dicer expression was regulated at the transcription level by E1A, through activation of an MAPK14/CEBPα pathway. Our findings define a mechanism of E1A-mediated chemosensitization for paclitaxel, which is based upon the suppression of breast cancer stem-like cells, with potential implications for the diagnosis and treatment of breast cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=84977522315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977522315&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-15-2555

DO - 10.1158/0008-5472.CAN-15-2555

M3 - Article

C2 - 27216190

AN - SCOPUS:84977522315

VL - 76

SP - 3916

EP - 3928

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 13

ER -